Maelstrom Research Staging | ISVaC_12_months_post_dose

ISVaC_12_months_post_dose_1

Networks -

Variables -

Associated study ISVaC Contingency Table

Population

ISVaC population

The population is composed of healthcare workers from British Columbia at least 18 years of age who are following a 4-month COVID-19 vaccine schedule.

Selection Criteria

Minimum age

Newborns

Twins

Countries

Canada

Territory

Greater Vancouver Area

Ethnic Origin

Health Status

Other Criteria

Healthcare workers are selected for this study.

Participants are excluded if they do not receive two COVID-19 vaccine doses within their vaccine schedule or if they did not receive any vaccine doses within the study period. The type of COVID-19 vaccine is limited to Pfizer//BioNTech, Moderna, Astra Zeneca, and Johnson & Johnson.

Supplementary Information about selection criteria

Recruitment

Sources of recruitment

Specific population
Participants from existing studies

Specific Population

Other specific population : Healthcare workers from BC

Supplementary Information

Some participants are recruited from the COVID-19 Occupational Risks, Seroprevalence and Immunity among Paramedics (CORSIP).

Participants from Existing Studies

COVID-19 Occupational Risks, Seroprevalence and Immunity among Paramedics (CORSIP)

Number of Participants

Number of Participants: 279
Number of Participants with Biological Samples: 279

More info

Data Collection Event

ISVaC - 12 months post-dose 1

Information was collected about COVID-19 testing (test result, type of test, date of test). Blood samples were collected.

More info

Collected Dataset / ISVaC_12_months_post_dose_1

ISVaC_12_months_post_dose_1

Population

ISVaC population

Data Collection Event

ISVaC - 12 months post-dose 1

Files

Variables Classifications